A Baby From Three
By Govind Vijaykumar,
The Asian Age
| 03. 08. 2015
[Quotes CGS's Marcy Darnovsky]
Untitled Document
Within a year, the world could see the first of what’s being described as the three-parent baby. And it’s one of mankind’s riskiest endeavours
There’s currently tension within the world’s scientific community. Groups are hurling accusations at each other — ranging from manipulation of data, blatant disregard for human life and for having the sort of enthusiasm that kills off any lab-based endeavour. Whilst one group prepares to announce to the world a life-changing procedure, the other maintains that we have collectively jumped the gun.
All this over a baby… the first ever to be born as a result of modification, rather than just natural progression — a child born from three different humans.
What it’s all about
The idea is simple. A procedure will replace faulty, trouble-causing DNA in the mother’s egg with healthy DNA from a donor woman allowing the child to possess, for the first time in our evolutionary history, genetic inputs from two mothers and one father. Proponents of this technique believe an injection of healthy donor DNA will cancel out life-threatening genetic conditions...
Related Articles
By Rhys Blakely, The Times | 06.24.2025
Scientists have created fertile mice from male genetic material alone, a breakthrough that could one day open the door to human babies who inherit their genes from two fathers.
The experiment, led by Professor Yanchang Wei at Shanghai Jiao Tong...
By Ron Leuty, San Francisco Business Times | 06.16.2025
23andMe's two-step sale to a nonprofit led by former CEO Anne Wojcicki is nothing more than a dance around California's genetic privacy law, state Attorney General Rob Bonta said in a filing late Monday, one day before a judge will...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Gina Kolata, The New York Times | 06.20.2025
A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need...